
    
      Patients will be examined pre-operatively to up to 3 years post-operatively. One eligible eye
      will be selected as a target eye for efficacy analysis. If both eyes are eligible, the eye in
      which the IOL is implanted first will be selected as the target eye.

      An interim analysis of results through Visit 4 (Day 120-180) is provided.
    
  